Former hockey pro sets new goal as Biogen CFO

21 November 2017
jeff_capello_large-1

Jeffrey Capello has been named executive vice president and chief financial officer (CFO) of US biotech company Biogen (Nasdaq: BIIB).

Mr Capello has 26 years of experience in finance including in the CFO roles with Beacon Health Options and Ortho Clinical Diagnostics, Boston Scientific Corporation, and Perkin Elmer. A certified accountant, he also spent time running his own company and working with the accounting firm PwC.

But some will be struck by another detail on his CV – his two years spent as a professional ice hockey player in the 1980s.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology